Kazuo Nagura
Gifu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kazuo Nagura.
Cancer Epidemiology, Biomarkers & Prevention | 2008
Masahito Shimizu; Yasushi Fukutomi; Mitsuo Ninomiya; Kazuo Nagura; Tomohiro Kato; Hiroshi Araki; Masami Suganuma; Hirota Fujiki; Hisataka Moriwaki
Background: Experimental studies indicate the chemopreventive properties of green tea extract (GTE) on colorectal cancer. Epidemiologically, green tea consumption of >10 cups daily reduced colorectal cancer risk in Japanese. Because colorectal adenomas are the precursors to most sporadic colorectal cancers, we conducted a randomized trial to determine the preventive effect of GTE supplements on metachronous colorectal adenomas by raising green tea consumption in the target population from an average of 6 cups (1.5 g GTE) daily to ≥10 cups equivalent (2.5 g GTE) by supplemental GTE tablets. Methods: We recruited 136 patients, removed their colorectal adenomas by endoscopic polypectomy, and 1 year later confirmed the clean colon (i.e., no polyp) at the second colonoscopy. The patients were then randomized into two groups while maintaining their lifestyle on green tea drinking: 71 patients supplemented with 1.5 g GTE per day for 12 months and 65 control patients without supplementation. Follow-up colonoscopy was conducted 12 months later in 125 patients (65 in the control group and 60 in the GTE group). Results: The incidence of metachronous adenomas at the end-point colonoscopy was 31% (20 of 65) in the control group and 15% (9 of 60) in the GTE group (relative risk, 0.49; 95% confidence interval, 0.24-0.99; P < 0.05). The size of relapsed adenomas was also smaller in the GTE group than in the control group (P < 0.001). No serious adverse events occurred in the GTE group. Conclusion: GTE is an effective supplement for the chemoprevention of metachronous colorectal adenomas. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3020–5)
Journal of Gastroenterology | 2000
Katsuhisa Toda; Ichiro Yasuda; Youichi Nishigaki; Masamichi Enya; Tetsuya Yamada; Kazuo Nagura; Jun-ichi Sugihara; Tatsuo Wakahara; Eiichi Tomita; Hisataka Moriwaki
Abstract: Inflammatory pseudotumor (IPT) of the liver is a rare benign variant of hepatic masses, and its exact etiology has not been elucidated. We report a case of IPT associated with primary sclerosing cholangitis (PSC). The patient was a 50-year-old man admitted to our hospital because of jaundice. Abdominal ultrasonography (US) and computed tomography showed multiple dilations of the intrahepatic bile ducts and multiple masses in the liver. On magnetic resonance imaging, the masses were slightly hypointense on T1-weighted images and slightly hyperintense on T2-weighted images. On T1-weighted images after the bolus infusion of Gd chelate, the masses had no contrast enhancement, and they were hypointense in the arterial phase and portal venous phase. However, they were slightly enhanced and became almost isointense relative to the surrounding normal liver parenchyma in the delayed phase. Endoscopic retrograde cholangiography demonstrated multiple irregular strictures and dilations of the intrahepatic bile ducts. Angiography demonstrated no abnormal findings, but, interestingly, subsequent dynamic CO2-enhanced US showed a strongly hyperechoic string, indicating that an artery had penetrated through the hypoechoic mass. A US-guided percutaneous needle biopsy revealed that the lesions were morphologically comparable to IPT. After cholangiography and microscopic analysis of the tumor, the final diagnosis was determined to be IPT of the liver with PSC. A number of previous reports have suggested a possible relationship between IPT and PSC, based on pathological findings. This report confirmed, based on clinical findings, that PSC is one of the causes of hepatic IPT.
European Journal of Gastroenterology & Hepatology | 1998
Ichiro Yasuda; Eiichi Tomita; Hisataka Moriwaki; Tomohiro Kato; Tatsuo Wakahara; Jun-ichi Sugihara; Kazuo Nagura; Youichi Nishigaki; Akihiko Sugiyama; Masamichi Enya
Background Endoscopic papillary balloon dilatation (EPBD) is generally considered a safe and effective technique for removal of common bile duct (CBD) stones. However, some reports have prompted concern about the risk of pancreatitis following the procedure, and it seems to be more difficult and to require adjunctive procedures more frequently in patients with large stones. Aims To analyse the factors influencing pancreatitis after the procedure, and to examine which is the more suitable adjunct for treating large stones, mechanical lithotripsy (ML) or extracorporeal Shockwave lithotripsy (ESWL). Patients and methods EPBD was performed in 92 patients, including 40 with large stones (≥ 12 mm). These 40 patients were randomly assigned to two groups receiving ML or ESWL to fragment stones (20 patients each). Results Complete ductal clearance was obtained in all 92 patients. Significant elevation of the serum amylase level compared with the prior value (> 300 IU/I) was observed in 26 (28%), and eight (8.7%) developed clinical pancreatitis. To assess the influence of various factors on the amylase level, multivariate analysis was used. The number of stones and the time required for treatment had a significant influence on the incidence of increased amylase level (P < 0.05), and ML also significantly increased it (P < 0.05). On the other hand, the amylase level remained low in the ESWL group. ML caused elevation of amylase level in 11 patients (55%), while three (15%) had elevation after ESWL. Conclusions In patients with multiple stones, elevation of the amylase level is more frequent This seems to be because repeated cannulation and much time is required for treatment. In patients with large stones, the rate was also high if ML was used, but was low when ESWL was used. ESWL may reduce the incidence of pancreatitis.
Kanzo | 1989
Hiroo Ohnishi; Hisataka Moriwaki; Naoki Hoshiyama; Kazuo Nagura; Masaya Saitoh; Masami Ohyama; Satoshi Nishino; Ryu Pei; Shoko Takano; Tsutomu Sakai; Eiichi Tomita; Yasutoshi Muto
Ara-A療法10例,ステロイド離脱療法12例およびその併用療法12例と,これら治療未施行の32例の臨床経過を推計学的に検討した.Kaplan-Meier法にて累積Seronegative (SN)率を求め,さらにこれをWeibull変換し検討した年間SN率は,いずれの治療でも対照群に比し有意に高く(p<0.05),また有意に早く(p<0.05) SNが誘導された.治療開始時GPT値200IU/l以上の症例での検討でも,治療群では対照群に比し有意に早く(p<0.05) SNが誘導されたが,200IU/l未満では誘導時期に差異はみられなかった.しかし各治療群ではいずれも対照群に比し有意に高い年率を有する群と,対照群と同様な年率を持つ2つの群が存在し,その変換点は6~7.5カ月であった.従って,B型慢性肝炎に対する抗ウイルス療法は原則としてGPT値200IU/l以上の症例を対象とし,6~7.5カ月後もHBe抗原が持続する場合には,別の治療法を施行することで良好な成績が得られるものと考えられた.
Gastrointestinal Endoscopy | 1995
Ichiro Yasuda; Eiichi Tomita; Kazuo Nagura; Youichi Nishigaki; Osamu Yamada; Hideki Kachi
Journal of Cancer Research and Clinical Oncology | 2002
Yasushi Fukutomi; Hisataka Moriwaki; Seisuke Nagase; Tomoo Naito; Yoshiyuki Miwa; Yasuhiro Yamada; Hiroshi Araki; Masataka Okuno; Kazuo Nagura; Tomohiro Kato; Mitsuo Ninomiya
Kanzo | 1989
Hiroo Ohnishi; Hisataka Moriwaki; Kazuo Nagura; Pei Ryu; Masahito Nagaki; Eiichi Tomita; Yasutoshi Muto
Acta Gastro-Enterologica Belgica | 2003
Eiichi Tomita; Akihiro Kanno; Masamichi Enya; Kazuo Nagura; Hiromi Tanemura
Acta Gastro-Enterologica Belgica | 1997
Yuji Tanaka; Ichiro Yasuda; Eiichi Tomita; Kazuo Nagura; Yoshihiko Matsuno; Ken Gotoh; Takaya Ohnishi; Hisao Asano; Youichi Nishigaki; Takeshi Takahashi; Tatsuo Wakahara; Tetsuya Yamada
Acta scholae medicinalis universitatis in Gifu | 1994
Kazuo Nagura; Hiroo Ohnishi; Yasutoshi Muto